Recent study in our laboratory using the DNA S1 nuclease analysis of Johnson (3) Previously, Lee and Riemann (5), using DNA-DNA membrane competition analyses, demonstrated that toxigenic strains of Clostridium botulinum (van Ermengem 1896) Bergey, Harrison, Breed, Hammer, and Huntoon 1923 were genetically very highly related to widely recognized strains of C. sporogenes. Thus, these three proteolytic species are the same genetic entity. The mechanism by which some strains gain toxigenicity is not known, but the property is reasonably stable, and the neurotoxin produced is among the most potent known to humanity. Although there appear to be slight differences in the cellular fatty acid composition of toxigenic strains and that of many nontoxigenic strains (l), only toxin tests in animals can differentiate the strains with certainty.
Recent study in our laboratory using the DNA S1 nuclease analysis of Johnson (3) showed that the type strains of Clostridium sporogenes (Mechnikoff 1908 ) Bergey, Harrison, Breed, Hammer, and Huntoon 1923 and Clostridium putrificum (Trevisan 1889) Reddish and Rettger 1922 (VPI 4440-lT = ATCC 25784T) are genetically homologous, with a mean similarity of 92% (based on four analyses).
Previously, Lee and Riemann (5), using DNA-DNA membrane competition analyses, demonstrated that toxigenic strains of Clostridium botulinum (van Ermengem 1896) Bergey, Harrison, Breed, Hammer, and Huntoon 1923 were genetically very highly related to widely recognized strains of C. sporogenes. Thus, these three proteolytic species are the same genetic entity. The mechanism by which some strains gain toxigenicity is not known, but the property is reasonably stable, and the neurotoxin produced is among the most potent known to humanity. Although there appear to be slight differences in the cellular fatty acid composition of toxigenic strains and that of many nontoxigenic strains (l), only toxin tests in animals can differentiate the strains with certainty.
The name C. putrificum has priority over the others, but it is not well recognized in the broad fields of public health and medicine and in the food and pharmacological industries. The type strain of C. putrifcum is not toxigenic, as opposed to C. botulirtum strains, which are considered to be Class I11 pathogens and are distributed by the American Type Culture Collection only with signed statements assuming all risks and responsibilities for laboratory handling (2). Use of the single name C. putrificum, which does not denote the significant difference between toxigenic, or C. botulinum, strains and nontoxigenic strains, would present serious health risks. Thus, in relation to C. botulinum, we request that the name C. putrificum be rejected and listed as a nomen periculosum ). For the toxigenic strains, we request that C. botulinum be placed on the list of conserved names (Rule 23a
After the rejection of the name C. putrificum as a perilous name, C. botulinum would have priority over the common nontoxigenic soil species C. sporogenes. Strains of C. sporogenes have long been used by the canning industry for quality control of food preservation procedures because it is well established that procedures which destroy C. sporogenes also destroy the deadly C. botulinurn. To avoid major confusion and tremendous public, medical, industrial, and educational expense (not to mention possible public panic) that would result if all strains of this genetic entity were labeled C. botulinum, we request conservation of the name C. sporogenes for the nontoxigenic strains (Rules 23a and 56b [4] ).
We believe that these requests best serve the first principle and purpose of nomenclature, which include stability of names and rejection of names that may cause error or confusion (4). Circumscription of the species C. botulinum and C. sporogenes to include toxigenic and nontoxigenic strains, respectively, further serves Principle 8 of the bacteriological code (4).
